As reported, CD44 in the basal layer oftumor cellular epidermis could be specifically recognized by HA (Misra et al., 2015), indicating that the over-expressed CD44 on thesurface of tumor cells could be used as a specific receptor for targeted drug delivery. The gene discussed is CD44; the disease is neoplasm.